Showing results (351-360 of 398) with videos related to

Sort By:
Pageof 40
European Journal of Heart Failure|June 26, 2020
Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registriesWouter Ouwerkerk, Tiew-Hwa K Teng, Jasper Tromp, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 30, 2023
Systemic oxidative stress associates with disease severity and outcome in patients with new-onset or worsening heart failureMarie-Sophie L Y de Koning, Johanna E Emmens, Esteban Romero-Hernández, et al.
European Journal of Heart Failure|November 13, 2019
Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatmentJan F Nauta, Yoran M Hummel, Jasper Tromp, et al.
European Journal of Heart Failure|February 20, 2018
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients-who is doing what to whom and how?Kenneth Dickstein, Camilla Normand, Angelo Auricchio, et al.
European Journal of Heart Failure|January 13, 2018
Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHFJoost C Beusekamp, Jasper Tromp, Haye H van der Wal, et al.
BMC Medicine|November 11, 2016
Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiativesJoão Pedro Ferreira, Nicolas Girerd, Pierpaolo Pellicori, et al.
Cardiovascular Research|March 8, 2023
Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failureGeorge Markousis-Mavrogenis, Waldemar B Minich, Ali A Al-Mubarak, et al.
International Journal of Cardiology|January 8, 2018
Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failureJozine M Ter Maaten, Adriaan A Voors, Kevin Damman, et al.
European Journal of Heart Failure|April 4, 2020
A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failureIziah E Sama, Rebecca J Woolley, Jan F Nauta, et al.
The New England Journal of Medicine|September 1, 2006
Celecoxib for the prevention of sporadic colorectal adenomasMonica M Bertagnolli, Craig J Eagle, Ann G Zauber, et al.
Pageof 40